LMIR3, Recombinant, Human (CMRF35-like Molecule 1, CLM-1, CD300 Antigen-like Family Member F, Immune Receptor Expressed on Myeloid Cells 1, IREM-1, Immunoglobulin Superfamily Member 13, IgSF13, CD300f, NK Inhibitory Receptor, CD300LF, CD300F, CLM1, IGSF13

LMIR3, Recombinant, Human (CMRF35-like Molecule 1, CLM-1, CD300 Antigen-like Family Member F, Immune Receptor Expressed on Myeloid Cells 1, IREM-1, Immunoglobulin Superfamily Member 13, IgSF13, CD300f, NK Inhibitory Receptor, CD300LF, CD300F, CLM1, IGSF13

Size

0,05 mg

Catalog no.

MBS636802

Price

851 EUR

Buy
NameValue
Tissue cells
Group recombinants
Source Recombinants or rec. proteins
Other size please contact us to order other different size
Properties Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Description Antigens are peptides or recombinant or native dependent on the production method.Complexes, systems, regulators, immune RNAs and non immune controls that can react with a specific antigen epitope.Whole adhesion and interacting molecules are present in lysates used as reference for ELISA quantification of these molecules and their subunits.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.